Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Golden Adam H. — Avalyn Pharma Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Golden Adam H.

Golden Adam H.

General Counsel at Avalyn Pharma Inc. · on record since Apr 29, 2026

Insider trading activity of Golden Adam H.

Transactions on record: 1; since May 4, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 4, 2026

Figures computed from official regulatory filings — methodology.

Companies where Golden Adam H. has traded

Avalyn Pharma Inc.1 tx · May 4, 2026

Track record of Golden Adam H.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Golden Adam H.

Co-insiders of Golden Adam H.

Baranowski LynAvalyn Pharma Inc.
Carlson Douglas RAvalyn Pharma Inc.
Carroll JillAvalyn Pharma Inc.
Congleton JonAvalyn Pharma Inc.
FMR LLCAvalyn Pharma Inc.
Friedman David MatthewAvalyn Pharma Inc.
George SimeonAvalyn Pharma Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Haviland KateAvalyn Pharma Inc.

Lavelle ErinAvalyn Pharma Inc.

Lazarus HowardAvalyn Pharma Inc.

Novo A/SAvalyn Pharma Inc.

Rhodes MelissaAvalyn Pharma Inc.

SR ONE CAPITAL MANAGEMENT, LLCAvalyn Pharma Inc.

Turner Heather DAvalyn Pharma Inc.

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Avalyn Pharma Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Avalyn Pharma Inc.	May 4, 2026	AwardD	254,891	0.00 USD	$0	SEC